 |
|
Adherence to Heart Failure Quality-of-Care Indicators in US Hospitals
Analysis of the ADHERE Registry
Gregg C. Fonarow, MD;
Clyde W. Yancy, MD;
J. Thomas Heywood, MD; for the ADHERE Scientific Advisory Committee, Study Group, and Investigators
Arch Intern Med. 2005;165:1469-1477.
Background Quality-of-care indicators have been developed for patients hospitalized with heart failure. However, little is known about current rates of conformity with these indicators or their variability across hospitals.
Methods Data from 81 142 admissions occurring between July 1, 2002, and December 31, 2003, at 223 academic and nonacademic hospitals in the United States participating in the Acute Decompensated Heart Failure National Registry (ADHERE) were analyzed. Rates of conformity with the 4 Joint Commission on Accreditation of Healthcare Organizations core performance measures—discharge instructions (HF-1), assessment of left ventricular function (HF-2), use of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction (HF-3), and smoking cessation counseling (HF-4)—as well as length of stay and in-hospital mortality rates were computed.
Results Across all hospitals, the median rates of conformity with HF-1, HF-2, HF-3, and HF-4 were 24.0%, 86.2%, 72.0%, and 43.2%, respectively. Rates of conformity at individual hospitals varied from 0% to 100%, with statistically significant differences between academic and nonacademic hospitals. Statistically significant positive independent predictors of overall conformity included the prevalence of comorbidities and the use of more intense pharmacologic management. Median hospital length of stay varied from 2.3 to 9.5 days, and in-hospital mortality varied from 0% to 11.1%.
Conclusions Among hospitals providing care for patients with heart failure, there is significant individual variability in conformity to quality-of-care indicators and clinical outcomes and a substantial gap in overall performance. Establishing educational initiatives and quality improvement systems to reduce this variability and eliminate this gap would be expected to substantially improve the care of these patients.
Author Affiliations: Division of Cardiology, Ahmanson-UCLA Cardiomyopathy Center, The David Geffen School of Medicine at the University of California, Los Angeles (Dr Fonarow); Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas (Dr Yancy); and Loma Linda University Medical Center, Loma Linda, Calif (Dr Heywood).
Group Information: A list of hospitals participating in ADHERE can be found at http://www.adhereregistry.com.
RELATED ARTICLES
Quality: The Need for Intelligent Efforts
Lawrence Baruch and Robert A. Phillips
Arch Intern Med. 2005;165(13):1455-1456.
EXTRACT
| FULL TEXT
Antithrombotic Therapy Practices in US Hospitals in an Era of Practice Guidelines
Victor F. Tapson, Thomas M. Hyers, Albert L. Waldo, David J. Ballard, Richard C. Becker, Joseph A. Caprini, Roger Khetan, Ann K. Wittkowsky, Kevin J. Colgan, Alicia C. Shillington, and for the NABOR (National Anticoagulation Benchmark and Outcomes Report) Steering Committee
Arch Intern Med. 2005;165(13):1458-1464.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF
Fonarow et al.
Circ Heart Fail 2008;1:98-106.
ABSTRACT
| FULL TEXT
Hospital Discharge Education for Patients With Heart Failure: What Really Works and What Is the Evidence?
Paul
Crit Care Nurse 2008;28:66-82.
FULL TEXT
Impact of Treatment Guidelines on Clinical and Economic Outcomes of Acute Decompensated Heart Failure
DiDomenico et al.
The Annals of Pharmacotherapy 2008;42:327-333.
ABSTRACT
| FULL TEXT
Association Between Performance Measures and Clinical Outcomes for Patients Hospitalized With Heart Failure
Fonarow et al.
JAMA 2007;297:61-70.
ABSTRACT
| FULL TEXT
The Year in Heart Failure
Tang and Francis
J Am Coll Cardiol 2006;48:2575-2583.
FULL TEXT
Compliance by Referring Physicians With Recommendations on Heart Failure Therapy from a Tertiary Center
Rocca et al.
J CARDIOVASC PHARMACOL THER 2006;11:85-92.
ABSTRACT
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial
Ahmed et al.
Eur Heart J 2006;27:178-186.
ABSTRACT
| FULL TEXT
The Year in Heart Failure
Tang and Francis
J Am Coll Cardiol 2005;46:2125-2133.
FULL TEXT
Quality: The Need for Intelligent Efforts
Baruch and Phillips
Arch Intern Med 2005;165:1455-1456.
FULL TEXT
|
